Evidence map›Paper›PMID 36253808›Full record

ArticleVeterinary medicine and science2023

First molecular detection of Equine Herpesvirus type 3 (EHV-3) in Chile.

Ignacio Troncoso, Rolando Calvanese, Fernando Saravia, Sebastián Muñoz-Leal, Nhur-Aischa Zegpi, René Ortega

Open access · goldAbstract readCase Reports
In one paragraph

Article in Veterinary medicine and science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ignacio TroncosoSchool of Veterinary Medicine, Faculty of Veterinary Medicine and Agronomy, Universidad de las Americas, Concepción, Chile.
Rolando CalvaneseManager of the Equine Tracer Center, Chilean Army Agreement -INDAP, Municipality of Bulnes and San Carlos, Ñuble, Chile.
Fernando SaraviaDepartment of Animal Sciences, Faculty of Veterinary Science, Universidad de Concepción, Chillán, Chile.
Sebastián Muñoz-LealDepartment of Animal Sciences, Faculty of Veterinary Science, Universidad de Concepción, Chillán, Chile.
Nhur-Aischa ZegpiPathology Department, Faculty of Veterinary Science, Universidad de Concepción, Chillán, Chile.
René OrtegaPathology Department, Faculty of Veterinary Science, Universidad de Concepción, Chillán, Chile.ORCID 0000-0003-4416-6400
University of Concepción · CLFundación Chile · CLUniversidad Adventista de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Equine coital rash (ECE) is a highly contagious benign infection that induces lesions on external genitals, and it is caused by the equine herpesvirus type 3 (EHV-3). Although the disease is globally distributed, its presence in Chile has not been documented from a genetic point of view. Here, we performed polymerase chain reaction screenings for EHV-3 in lesions of external genitals in four horses belonging to a riding station at Bulnes, Ñuble Region, Chile. We sequenced a fragment of the glycoprotein G (gG) gene from three horses with clinical signs of ECE. The sequences were identical between them and 99.7% similar to a haplotype of EHV-3 detected in Brazil, and phylogenetically related with homologue from Japan, Russia and Brazil. Our results show the presence of EHV-3 for the first time in horses with ECE in Chile.

Indexed as

Herpesviridae InfectionsHerpesvirus 3, EquidHorse DiseasesAnimalsBase SequenceChileHorsesPolymerase Chain ReactionChilecoital exanthemaequineglycoproteinherpesvirusvenereal

Identifiers

PMID36253808
PMCPMC10029895
OpenAlexW4306659738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.